Careers  |  Sign In  |  Register

Latest in Endocrinology

Reuters Health • The Doctor's Channel Daily Newscast

Amlodipine best for hypertension even with higher heart rate

NEW YORK (Reuters Health) – Amlodipine-based therapy is still a better treatment for uncomplicated hypertension than atenolol-based therapy, even in patients with higher baseline heart rates, according to a report in the Journal of the American College of Cardiology for September 22. Some guidelines...

Reuters Health • The Doctor's Channel Daily Newscast

Darusentan useful for treatment-resistant hypertension

NEW YORK (Reuters Health) – Darusentan, a selective endothelin-receptor blocker, can reduce blood pressure in patients who have not reached their target levels using three or more antihypertensive agents, according to a report in the September 14th online issue of The Lancet. “The use of this drug...

Reuters Health • The Doctor's Channel Daily Newscast

Increased fracture risk seen among older users of thiazolidinediones

NEW YORK (Reuters Health) - Thiazolidinedione treatment of diabetes in older adults is associated with an increased fracture risk, according to a report in the August issue of The Journal of Clinical Endocrinology and Metabolism. "Use these drugs with caution in older adults with fracture risks," Dr....